Preliminary data from a study done by Targovax show a numerical advantage in Progression-Free Survival in patients treated with ONCOS-102.
Phase II of a clinical trial involving surgery, radiation, and chemotherapy is actively recruiting patients with pleural mesothelioma.
The combination of imaging features with a history of asbestos exposure may be enough information to diagnose pleural mesothelioma.
A non-invasive treatment that combines chemotherapy with electrical currents to shrink mesothelioma tumors appears to be working for a group of patients.
The European Thoracic Oncology Platform (ETOP) recently completed a disappointing phase 3 trial for mesothelioma treatment.
Phase II of a clinical trial is recruiting mesothelioma patients to test the effectiveness of two immunotherapy medications in combination.